396 related articles for article (PubMed ID: 10870111)
1. A novel method utilising markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes.
Parisotto R; Gore CJ; Emslie KR; Ashenden MJ; Brugnara C; Howe C; Martin DT; Trout GJ; Hahn AG
Haematologica; 2000 Jun; 85(6):564-72. PubMed ID: 10870111
[TBL] [Abstract][Full Text] [Related]
2. Detection of recombinant human erythropoietin abuse in athletes utilizing markers of altered erythropoiesis.
Parisotto R; Wu M; Ashenden MJ; Emslie KR; Gore CJ; Howe C; Kazlauskas R; Sharpe K; Trout GJ; Xie M
Haematologica; 2001 Feb; 86(2):128-37. PubMed ID: 11224480
[TBL] [Abstract][Full Text] [Related]
3. Reticulocyte parameters as potential discriminators of recombinant human erythropoietin abuse in elite athletes.
Parisotto R; Gore CJ; Hahn AG; Ashenden MJ; Olds TS; Martin DT; Pyne DB; Gawthorn K; Brugnara C
Int J Sports Med; 2000 Oct; 21(7):471-9. PubMed ID: 11071048
[TBL] [Abstract][Full Text] [Related]
4. Effects of prolonged low doses of recombinant human erythropoietin during submaximal and maximal exercise.
Russell G; Gore CJ; Ashenden MJ; Parisotto R; Hahn AG
Eur J Appl Physiol; 2002 Mar; 86(5):442-9. PubMed ID: 11882931
[TBL] [Abstract][Full Text] [Related]
5. Development of reference ranges in elite athletes for markers of altered erythropoiesis.
Sharpe K; Hopkins W; Emslie KR; Howe C; Trout GJ; Kazlauskas R; Ashenden MJ; Gore CJ; Parisotto R; Hahn AG
Haematologica; 2002 Dec; 87(12):1248-57. PubMed ID: 12495898
[TBL] [Abstract][Full Text] [Related]
6. Second-generation blood tests to detect erythropoietin abuse by athletes.
Gore CJ; Parisotto R; Ashenden MJ; Stray-Gundersen J; Sharpe K; Hopkins W; Emslie KR; Howe C; Trout GJ; Kazlauskas R; Hahn AG
Haematologica; 2003 Mar; 88(3):333-44. PubMed ID: 12651273
[TBL] [Abstract][Full Text] [Related]
7. Effect of physical fitness and endurance exercise on indirect biomarkers of recombinant erythropoietin misuse.
Abellan R; Ventura R; Pichini S; Palmi I; Bellver M; Olive R; Pacifici R; Pascual JA; Zuccaro P; Segura J
Int J Sports Med; 2007 Jan; 28(1):9-15. PubMed ID: 16804802
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietic response induced by recombinant human erythropoietin in anemic cancer patients candidate to major abdominal surgery.
Braga M; Gianotti L; Gentilini O; Vignali A; Di Carlo V
Hepatogastroenterology; 1997; 44(15):685-90. PubMed ID: 9222672
[TBL] [Abstract][Full Text] [Related]
9. Effects of subcutaneous recombinant human erythropoietin in normal subjects: development of decreased reticulocyte hemoglobin content and iron-deficient erythropoiesis.
Brugnara C; Colella GM; Cremins J; Langley RC; Schneider TJ; Rutherford CJ; Goldberg MA
J Lab Clin Med; 1994 May; 123(5):660-7. PubMed ID: 8195672
[TBL] [Abstract][Full Text] [Related]
10. Analysis of human reticulocyte genes reveals altered erythropoiesis: potential use to detect recombinant human erythropoietin doping.
Varlet-Marie E; Audran M; Lejeune M; Bonafoux B; Sicart MT; Marti J; Piquemal D; Commes T
Haematologica; 2004 Aug; 89(8):991-7. PubMed ID: 15339684
[TBL] [Abstract][Full Text] [Related]
11. Hematological indices of erythropoietin administration in athletes.
Casoni I; Ricci G; Ballarin E; Borsetto C; Grazzi G; Guglielmini C; Manfredini F; Mazzoni G; Patracchini M; De Paoli Vitali E
Int J Sports Med; 1993 Aug; 14(6):307-11. PubMed ID: 7691771
[TBL] [Abstract][Full Text] [Related]
12. Identification of blood erythroid markers useful in revealing erythropoietin abuse in athletes.
Magnani M; Corsi D; Bianchi M; Paiardini M; Galluzzi L; Gargiullo E; Parisi A; Pigozzi F
Blood Cells Mol Dis; 2001; 27(3):559-71. PubMed ID: 11355895
[TBL] [Abstract][Full Text] [Related]
13. Modifications of erythropoiesis in myelodysplastic syndromes treated with recombinant erythropoietin as evaluated by soluble transferrin receptor, high fluorescence reticulocytes and hypochromic erythrocytes.
Musto P; Modoni S; Alicino G; Savino A; Longo A; Bodenizza C; Falcone A; D'Arena G; Scalzulli P; Perla G
Haematologica; 1994; 79(6):493-9. PubMed ID: 7896207
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
Phair JP; Abels RI; McNeill MV; Sullivan DJ
Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human erythropoietin and autologous blood donation.
Levine EA; Rosen AL; Gould SA; Sehgal LR; Egrie JC; Browne JK; Sehgal HL; Moss GS
Surgery; 1988 Aug; 104(2):365-9. PubMed ID: 3400066
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of different dosing regimens for recombinant human erythropoietin in a simulated perisurgical setting: the importance of iron availability in optimizing response.
Rutherford CJ; Schneider TJ; Dempsey H; Kirn DH; Brugnara C; Goldberg MA
Am J Med; 1994 Feb; 96(2):139-45. PubMed ID: 8109598
[TBL] [Abstract][Full Text] [Related]
17. Effects of exercise on the secondary blood markers commonly used to suspect erythropoietin doping.
Robinson N; Saugy M; Mangin P
Clin Lab; 2003; 49(1-2):57-62. PubMed ID: 12593476
[TBL] [Abstract][Full Text] [Related]
18. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
Chen YC; Hung SC; Tarng DC
Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
[TBL] [Abstract][Full Text] [Related]
19. [Effect of recombinant human erythropoietin on autologous blood donation for heart surgery].
Szöcs M; Donauer E; Simon J; Gál G; Kovács G
Orv Hetil; 1995 Aug; 136(33):1777-81. PubMed ID: 7651714
[TBL] [Abstract][Full Text] [Related]
20. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.
Cowgill LD; James KM; Levy JK; Browne JK; Miller A; Lobingier RT; Egrie JC
J Am Vet Med Assoc; 1998 Feb; 212(4):521-8. PubMed ID: 9491159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
